Evidence map›Paper›PMID 39186139›Full record

ArticleJournal of fluorescence2025

Highly Reversible "On-Off-On" Fluorescence Switch Governed by pH, Utilizing Bis(Benzimidazole) Derivatives with Varied Link Groups.

Weijian Xue, Xiangyu Ling, Huiqian Li, Yuhang Liu, Bing Zhao, Yanbing Yin

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weijian XueHeilongjiang Provincial Key Laboratory of Surface Active Agent and Auxiliary, Technology Innovation Center of Industrial Hemp for State Market Regulation, Institute of Chemistry and Chemical Engineering, Qiqihar University, Qiqihar, 161006, PR China. hehexueweijian@163.com.
Xiangyu LingHeilongjiang Provincial Key Laboratory of Surface Active Agent and Auxiliary, Technology Innovation Center of Industrial Hemp for State Market Regulation, Institute of Chemistry and Chemical Engineering, Qiqihar University, Qiqihar, 161006, PR China.
Huiqian LiHeilongjiang Provincial Key Laboratory of Surface Active Agent and Auxiliary, Technology Innovation Center of Industrial Hemp for State Market Regulation, Institute of Chemistry and Chemical Engineering, Qiqihar University, Qiqihar, 161006, PR China.
Yuhang LiuHeilongjiang Provincial Key Laboratory of Surface Active Agent and Auxiliary, Technology Innovation Center of Industrial Hemp for State Market Regulation, Institute of Chemistry and Chemical Engineering, Qiqihar University, Qiqihar, 161006, PR China.
Bing ZhaoHeilongjiang Provincial Key Laboratory of Surface Active Agent and Auxiliary, Technology Innovation Center of Industrial Hemp for State Market Regulation, Institute of Chemistry and Chemical Engineering, Qiqihar University, Qiqihar, 161006, PR China.
Yanbing YinHeilongjiang Provincial Key Laboratory of Surface Active Agent and Auxiliary, Technology Innovation Center of Industrial Hemp for State Market Regulation, Institute of Chemistry and Chemical Engineering, Qiqihar University, Qiqihar, 161006, PR China.

Funding

National Natural Science Foundation 22101147
6 · The paper itself

Abstract

In this work, a series of dibenzimidazole derivatives 1-4, act as highly reversible colorimetric and fluorescent pH chemosensor, were designed and synthesized. Excellent reversible pH response of these sensors could be found by a specific pH change through obvious fluorescent color changes. The response is not affected by common cations (including Al

Indexed as

Bis(Benzimidazole) derivativesControlled by pHFluorescence switchHighly reversible

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.